Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1⁺ smooth muscle cells.
[BACKGROUND] Stromal remodeling constitutes a hallmark of gastric cancer (GC) progression, yet the intercellular signaling networks orchestrating this process remain incompletely understood.
APA
Cheng K, Xu J, et al. (2026). Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1⁺ smooth muscle cells.. BMC cancer, 26(1). https://doi.org/10.1186/s12885-026-15647-6
MLA
Cheng K, et al.. "Spatial atlas of gastric cancer reveals macrophage-driven stromal activation via ICAM1⁺ smooth muscle cells.." BMC cancer, vol. 26, no. 1, 2026.
PMID
41761123
Abstract
[BACKGROUND] Stromal remodeling constitutes a hallmark of gastric cancer (GC) progression, yet the intercellular signaling networks orchestrating this process remain incompletely understood.
[METHODS] Single-cell RNA sequencing (scRNA-seq) data from 172,763 cells (GSE167297: = 30,365; OMIX001073: = 142,398) were integrated with spatial transcriptomic profiles from 10 GC samples (GSE251950). The analyses encompassed single-cell integration, spatial deconvolution, spatial architecture reconstruction, identification of tertiary lymphoid structures (TLSs), and inference of intercellular communication networks. Clinical relevance was evaluated through survival analyses across multiple independent public cohorts. Key computational findings were validated using multiplex immunofluorescence staining, quantitative real-time PCR, and transwell co-culture migration assays.
[RESULTS] A single-cell–resolved spatial atlas of the GC tumor microenvironment (TME) was constructed. Spatial–cellular integration revealed aberrant immune cell redistribution, with enrichment of CD4⁺⁺⁺ and CD8_Trm-⁺ T cells in paratumor regions, indicating potential roles in immune surveillance and tumor restraint. Spatial architecture delineated six distinct microenvironmental niches: C0 (immune-active, TLS-enriched), C1 (dendritic cell-dominant, immunoregulatory), C2 (immune–stromal interface), C3/C4 (epithelial-rich tumor cores), and C5 (stromal-supportive). TLSs were predominantly localized within the immune-active C0 niche, representing mature immune hubs. Within the stromal C5 niche, a coordinated stromal activation mechanism was identified, mediated by a macrophage–smooth muscle cell (SMC)–fibroblast axis driven by synergistic macrophage-derived – and – signaling. Immunofluorescence co-localization and qPCR assays confirmed elevated expression of , , , and in tumor tissues. Functionally, Functionally, transwell co-culture assays demonstrated that macrophage-derived and were associated with enhanced SMCs proliferation and migratory capacity, while silencing either molecule significantly attenuated this effect. This dual signaling axis promoted ⁺ SMC proliferation and activation through PI3K/Akt pathway engagement and extracellular matrix (ECM) remodeling, resulting in extensive stromal reorganization and a pro-tumorigenic microenvironment. Across multiple cohorts, concurrent activation of and pathways was associated with significantly poorer overall survival compared with activation of either pathway alone, underscoring the prognostic and therapeutic relevance of this interaction.
[CONCLUSIONS] This study reconstructs the GC spatial architecture at single-cell resolution, and reveals a previously unrecognized macrophage-driven stromal activation program mediated by convergent – and – signaling. ⁺ SMCs emerge as key effectors and potential targets for stromal-directed therapy.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12885-026-15647-6.
[METHODS] Single-cell RNA sequencing (scRNA-seq) data from 172,763 cells (GSE167297: = 30,365; OMIX001073: = 142,398) were integrated with spatial transcriptomic profiles from 10 GC samples (GSE251950). The analyses encompassed single-cell integration, spatial deconvolution, spatial architecture reconstruction, identification of tertiary lymphoid structures (TLSs), and inference of intercellular communication networks. Clinical relevance was evaluated through survival analyses across multiple independent public cohorts. Key computational findings were validated using multiplex immunofluorescence staining, quantitative real-time PCR, and transwell co-culture migration assays.
[RESULTS] A single-cell–resolved spatial atlas of the GC tumor microenvironment (TME) was constructed. Spatial–cellular integration revealed aberrant immune cell redistribution, with enrichment of CD4⁺⁺⁺ and CD8_Trm-⁺ T cells in paratumor regions, indicating potential roles in immune surveillance and tumor restraint. Spatial architecture delineated six distinct microenvironmental niches: C0 (immune-active, TLS-enriched), C1 (dendritic cell-dominant, immunoregulatory), C2 (immune–stromal interface), C3/C4 (epithelial-rich tumor cores), and C5 (stromal-supportive). TLSs were predominantly localized within the immune-active C0 niche, representing mature immune hubs. Within the stromal C5 niche, a coordinated stromal activation mechanism was identified, mediated by a macrophage–smooth muscle cell (SMC)–fibroblast axis driven by synergistic macrophage-derived – and – signaling. Immunofluorescence co-localization and qPCR assays confirmed elevated expression of , , , and in tumor tissues. Functionally, Functionally, transwell co-culture assays demonstrated that macrophage-derived and were associated with enhanced SMCs proliferation and migratory capacity, while silencing either molecule significantly attenuated this effect. This dual signaling axis promoted ⁺ SMC proliferation and activation through PI3K/Akt pathway engagement and extracellular matrix (ECM) remodeling, resulting in extensive stromal reorganization and a pro-tumorigenic microenvironment. Across multiple cohorts, concurrent activation of and pathways was associated with significantly poorer overall survival compared with activation of either pathway alone, underscoring the prognostic and therapeutic relevance of this interaction.
[CONCLUSIONS] This study reconstructs the GC spatial architecture at single-cell resolution, and reveals a previously unrecognized macrophage-driven stromal activation program mediated by convergent – and – signaling. ⁺ SMCs emerge as key effectors and potential targets for stromal-directed therapy.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12885-026-15647-6.
같은 제1저자의 인용 많은 논문 (5)
- Vitamin D as a central modulator of thyroid diseases: mechanisms and clinical implications.
- Peptide-functionalized membrane camouflage for endogenous HS-induced photothermal immunotherapy of orthotopic colorectal cancer.
- Photothermal-Responsive Phase Transition of Proteoliposomes for Heat Shock Protein Sequestering against Cancer Thermoresistance.
- PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway.
- Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma.